Acrux Limited
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more
Acrux Limited (ARUXF) - Total Assets
Latest total assets as of June 2025: $7.22 Million USD
Based on the latest financial reports, Acrux Limited (ARUXF) holds total assets worth $7.22 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Acrux Limited - Total Assets Trend (2002–2025)
This chart illustrates how Acrux Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Acrux Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Acrux Limited's total assets of $7.22 Million consist of 66.5% current assets and 33.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.9% |
| Accounts Receivable | $3.79 Million | 52.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Acrux Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Acrux Limited's current assets represent 66.5% of total assets in 2025, a decrease from 98.3% in 2002.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 97.2% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 52.5% of total assets.
Acrux Limited Competitors by Total Assets
Key competitors of Acrux Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Acrux Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Acrux Limited generates 0.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Acrux Limited is currently not profitable relative to its asset base.
Acrux Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 1.61 | 4.63 |
| Quick Ratio | 1.07 | 1.61 | 4.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $323.00K | $ 2.26 Million | $ 9.68 Million |
Acrux Limited - Advanced Valuation Insights
This section examines the relationship between Acrux Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.54 |
| Latest Market Cap to Assets Ratio | 0.56 |
| Asset Growth Rate (YoY) | -19.4% |
| Total Assets | $7.22 Million |
| Market Capitalization | $4.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values Acrux Limited's assets below their book value (0.56 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Acrux Limited's assets decreased by 19.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Acrux Limited (2002–2025)
The table below shows the annual total assets of Acrux Limited from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $7.22 Million | -19.39% |
| 2024-06-30 | $8.96 Million | -32.53% |
| 2023-06-30 | $13.29 Million | -7.11% |
| 2022-06-30 | $14.30 Million | -38.69% |
| 2021-06-30 | $23.33 Million | +30.79% |
| 2020-06-30 | $17.84 Million | -27.00% |
| 2019-06-30 | $24.43 Million | -24.80% |
| 2018-06-30 | $32.49 Million | -31.32% |
| 2017-06-30 | $47.31 Million | -11.36% |
| 2016-06-30 | $53.37 Million | +10.05% |
| 2015-06-30 | $48.49 Million | -8.88% |
| 2014-06-30 | $53.22 Million | +0.62% |
| 2013-06-30 | $52.90 Million | -9.58% |
| 2012-06-30 | $58.50 Million | -0.84% |
| 2011-06-30 | $58.99 Million | -29.44% |
| 2010-06-30 | $83.61 Million | +139.21% |
| 2009-06-30 | $34.95 Million | -15.31% |
| 2008-06-30 | $41.27 Million | +102.60% |
| 2007-06-30 | $20.37 Million | -12.33% |
| 2006-06-30 | $23.23 Million | -25.28% |
| 2005-06-30 | $31.09 Million | +218.66% |
| 2004-06-30 | $9.76 Million | -24.04% |
| 2003-06-30 | $12.85 Million | -30.02% |
| 2002-06-30 | $18.36 Million | -- |